Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
CELG

Celgene

$93.85

-1.41 (-1.48%)

, JUNO

Juno Therapeutics

$84.98

-0.12 (-0.14%)

07:31
02/21/18
02/21
07:31
02/21/18
07:31
Hot Stocks
Celgene receives antitrust clearance for Juno Therapeutics acquisition »

Celgene Corporation…

CELG

Celgene

$93.85

-1.41 (-1.48%)

JUNO

Juno Therapeutics

$84.98

-0.12 (-0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Mar

  • 30

    May

Over a week ago
JUNO

Juno Therapeutics

$85.90

0.41 (0.48%)

17:00
02/07/18
02/07
17:00
02/07/18
17:00
Hot Stocks
Breaking Hot Stocks news story on Juno Therapeutics »

Crestline reduces stake…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CELG

Celgene

$100.34

-0.82 (-0.81%)

, JUNO

Juno Therapeutics

$85.57

-0.24 (-0.28%)

07:30
02/02/18
02/02
07:30
02/02/18
07:30
Hot Stocks
Celgene commences tender offer for Juno Therapeutics for $87 per share »

Celgene Corporation…

CELG

Celgene

$100.34

-0.82 (-0.81%)

JUNO

Juno Therapeutics

$85.57

-0.24 (-0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 25

    Mar

  • 30

    May

IOVA

Iovance Biotherapeutics

$13.70

-0.95 (-6.48%)

, GILD

Gilead

$85.46

4.27 (5.26%)

05:46
01/29/18
01/29
05:46
01/29/18
05:46
Recommendations
Iovance Biotherapeutics, Gilead, Celgene, Juno Therapeutics analyst commentary at Wells Fargo »

Iovance Biotherapeutics…

IOVA

Iovance Biotherapeutics

$13.70

-0.95 (-6.48%)

GILD

Gilead

$85.46

4.27 (5.26%)

CELG

Celgene

$105.17

0.78 (0.75%)

JUNO

Juno Therapeutics

$85.72

-0.03 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 06

    Feb

  • 07

    Feb

  • 12

    Feb

  • 16

    Feb

  • 25

    Mar

  • 30

    May

Over a month ago
JUNO

Juno Therapeutics

$85.86

-0.14 (-0.16%)

09:43
01/24/18
01/24
09:43
01/24/18
09:43
Downgrade
Juno Therapeutics rating change at Standpoint Research »

Juno Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMS

American Shared Hospital

$2.75

-0.0419 (-1.50%)

, BLFS

BioLife Solutions

$5.73

0.13 (2.32%)

07:14
01/24/18
01/24
07:14
01/24/18
07:14
Conference/Events
Phacilitate to hold a conference »

Cell & Gene Therapy…

AMS

American Shared Hospital

$2.75

-0.0419 (-1.50%)

BLFS

BioLife Solutions

$5.73

0.13 (2.32%)

SNE

Sony

$50.42

-0.38 (-0.75%)

CLLS

Cellectis

$34.17

1.68 (5.17%)

PSTI

Pluristem

$1.53

0.0101 (0.66%)

NOVS

Novistar Inc.

NOVN

Novan

$3.52

0.055 (1.59%)

CELG

Celgene

$104.55

1.64 (1.59%)

EVR

Evercore Partners

$97.70

0.15 (0.15%)

JUNO

Juno Therapeutics

$85.86

-0.14 (-0.16%)

PZRX

PhaseRx

$0.39

-0.0128 (-3.22%)

BIIB

Biogen

$346.75

-0.89 (-0.26%)

GEN

Genesis Healthcare

$0.94

-0.0133 (-1.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 25

    Jan

  • 25

    Jan

  • 25

    Jan

  • 31

    Jan

  • 16

    Feb

  • 08

    Mar

  • 25

    Mar

JUNO

Juno Therapeutics

$85.86

-0.14 (-0.16%)

, CELG

Celgene

$104.55

1.64 (1.59%)

04:51
01/24/18
01/24
04:51
01/24/18
04:51
Downgrade
Juno Therapeutics, Celgene rating change at Barclays »

Juno Therapeutics…

JUNO

Juno Therapeutics

$85.86

-0.14 (-0.16%)

CELG

Celgene

$104.55

1.64 (1.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

JUNO

Juno Therapeutics

$86.00

18.19 (26.83%)

, CELG

Celgene

$102.91

0.26 (0.25%)

09:34
01/23/18
01/23
09:34
01/23/18
09:34
Downgrade
Juno Therapeutics, Celgene rating change at Leerink »

Juno Therapeutics…

JUNO

Juno Therapeutics

$86.00

18.19 (26.83%)

CELG

Celgene

$102.91

0.26 (0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

CELG

Celgene

$102.91

0.26 (0.25%)

, JUNO

Juno Therapeutics

$86.00

18.19 (26.83%)

09:26
01/23/18
01/23
09:26
01/23/18
09:26
Recommendations
Celgene, Juno Therapeutics analyst commentary at RBC Capital »

Celgene price target…

CELG

Celgene

$102.91

0.26 (0.25%)

JUNO

Juno Therapeutics

$86.00

18.19 (26.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

CELG

Celgene

$102.91

0.26 (0.25%)

, JUNO

Juno Therapeutics

$86.00

18.19 (26.83%)

08:05
01/23/18
01/23
08:05
01/23/18
08:05
Recommendations
Celgene, Juno Therapeutics analyst commentary at Canaccord »

Celgene purchase adds…

CELG

Celgene

$102.91

0.26 (0.25%)

JUNO

Juno Therapeutics

$86.00

18.19 (26.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.